Neptune Wellness Solutions (NASDAQ:NEPT) Research Coverage Started at

Research analysts at started coverage on shares of Neptune Wellness Solutions (NASDAQ:NEPTGet Rating) (TSE:NTB) in a research report issued to clients and investors on Wednesday. The firm set a “sell” rating on the biotechnology company’s stock.

Neptune Wellness Solutions Price Performance

Neptune Wellness Solutions stock opened at $0.21 on Wednesday. The stock has a market cap of $2.48 million, a price-to-earnings ratio of -0.02 and a beta of 2.10. Neptune Wellness Solutions has a 12-month low of $0.20 and a 12-month high of $6.12. The company has a quick ratio of 0.38, a current ratio of 0.95 and a debt-to-equity ratio of 1.00. The business’s 50-day simple moving average is $0.49 and its 200 day simple moving average is $0.58.

Neptune Wellness Solutions (NASDAQ:NEPTGet Rating) (TSE:NTB) last issued its earnings results on Thursday, March 30th. The biotechnology company reported ($0.61) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.01) by $0.40. Neptune Wellness Solutions had a negative net margin of 125.83% and a negative return on equity of 93.21%. The company had revenue of $12.21 million for the quarter, compared to analyst estimates of $13.15 million. As a group, research analysts anticipate that Neptune Wellness Solutions will post -9.42 earnings per share for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently bought and sold shares of the company. Stifel Financial Corp acquired a new stake in Neptune Wellness Solutions during the 1st quarter worth $41,000. Morgan Stanley boosted its position in Neptune Wellness Solutions by 26,898.7% during the 4th quarter. Morgan Stanley now owns 544,833 shares of the biotechnology company’s stock worth $172,000 after acquiring an additional 542,815 shares during the last quarter. Citadel Advisors LLC bought a new position in shares of Neptune Wellness Solutions during the 3rd quarter worth approximately $43,000. Renaissance Technologies LLC raised its holdings in shares of Neptune Wellness Solutions by 12.6% in the third quarter. Renaissance Technologies LLC now owns 128,684 shares of the biotechnology company’s stock valued at $196,000 after purchasing an additional 14,395 shares during the last quarter. Finally, Virtu Financial LLC bought a new stake in shares of Neptune Wellness Solutions in the third quarter worth $64,000. Institutional investors own 5.07% of the company’s stock.

About Neptune Wellness Solutions

(Get Rating)

Neptune Wellness Solutions Inc, a health and wellness products company, specializes in the extraction, purification and formulation of cannabis products, as well as other specialty ingredients, such as MaxSimil, a patented ingredient that enhances the absorption of lipid-based nutraceuticals, and various other marine and seed oils.

Read More

Receive News & Ratings for Neptune Wellness Solutions Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neptune Wellness Solutions and related companies with's FREE daily email newsletter.